Android app Apple app link

Neurocrine Biosciences, Inc. (NBIX) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$130.10

$1.72 (1.34%)
Last update: 02:46 AM EST
Day's range
$127.79
Day's range
$130.98

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
02/17/2026 Truist Financial Danielle Brill $140.00 $128.98   8.54%
01/05/2026 UBS Ashwani Verma $188.00 $137.15   37.08%
10/29/2025 Truist Financial Danielle Brill $172.00 $139.90   22.94%
10/29/2025 Stifel Nicolaus Paul Matteis $183.00 $143.09   27.89%
10/29/2025 Needham Ami Fadia $184.00 $147.38   24.85%
10/29/2025 Jefferies Akash Tewari $174.00 $147.38   18.06%
10/09/2025 UBS Ashwani Verma $195.00 $139.49   39.79%
04/22/2025 H.C. Wainwright Andrew Fein $168.00 $101.74   65.13%
01/08/2025 UBS Ashwani Verma $162.00 $137.55   17.78%
10/31/2024 BMO Capital Evan David Seigerman $121.00 $120.27   0.61%
10/22/2024 Oppenheimer Jay Olson $192.00 $116.57   64.71%
10/10/2024 Raymond James Danielle Brill $155.00 $111.62   38.86%
09/13/2024 BMO Capital Evan David Seigerman $128.00 $122.29   4.67%
09/09/2024 Barclays Carter Gould $160.00 $120.17   33.14%
08/29/2024 RBC Capital Brian Abrahams $136.00 $123.76   9.89%
08/28/2024 Piper Sandler David Amsellem $159.00 $128.43   23.8%
07/12/2024 Morgan Stanley Jeffrey Hung $170.00 $146.50   16.04%
06/06/2024 RBC Capital Brian Abrahams $141.00 $133.69   5.47%
05/28/2024 UBS Ashwani Verma $193.00 $139.40   38.45%
05/13/2024 Evercore ISI Cory Kasimov $175.00 $136.15   28.53%
05/02/2024 Canaccord Genuity Sumant Kulkarni $164.00 $143.03   14.66%
05/02/2024 H.C. Wainwright Andrew Fein $160.00 $143.03   11.86%
04/23/2024 Wells Fargo Mohit Bansal $170.00 $139.35   22%
03/12/2024 Oppenheimer Jay Olson $200.00 $137.74   45.2%
11/01/2022 SVB Securities Marc Goodman $115.00 $119.36   -3.65%
11/01/2022 Robert W. Baird Brian Skorney $150.00 $119.36   25.67%
11/01/2022 H.C. Wainwright Andrew Fein $140.00 $119.36   17.29%
11/01/2022 Piper Sandler David Amsellem $103.00 $119.36   -13.71%
02/13/2022 H.C. Wainwright Andrew Fein $140.00 $86.52   61.81%
02/10/2022 Leerink Partners Marc Goodman $100.00 $85.53   16.92%
02/10/2022 Robert W. Baird Brian Skorney $117.00 $85.53   36.79%
02/10/2022 Stifel Nicolaus Paul Matteis $136.00 $85.53   59.01%
02/10/2022 Raymond James Danielle Brill $125.00 $85.53   46.15%
01/25/2022 Bank of America Securities Tazeen Ahmad $127.00 $75.51   68.19%
01/19/2022 Barclays Carter Gould $100.00 $72.80   37.36%
12/07/2021 Citigroup Neena Bitritto-Garg $129.00 $84.26   53.1%
11/01/2021 Cantor Fitzgerald Charles Duncan $123.00 $95.58   28.69%
11/01/2021 Evercore ISI Joshua Schimmer $130.00 $95.58   36.01%
08/05/2021 Canaccord Genuity Sumant Kulkarni $108.00 $89.57   20.58%
08/03/2021 Wedbush Laura Chico $112.00 $93.20   20.17%

Neurocrine Biosciences, Inc. FAQ's

Neurocrine Biosciences, Inc. has been rated by research analysts at Truist Financial, Needham, RBC Capital, Wedbush, Morgan Stanley, H.C. Wainwright in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.